Microarray Analysis of Gene Expression in Cultured Skin Substitutes Compared with Native Human Skin  by Smiley, Andrea K. et al.
Microarray Analysis of Gene Expression in Cultured Skin
Substitutes Compared with Native Human Skin
Andrea K. Smiley, Jennifer M. Klingenberg, Bruce J. Aronow,w Steven T. Boyce,z W. John Kitzmiller,z and
Dorothy M. Suppz
Research Department, Shriners Hospitals for Children, Cincinnati Burns Hospital, Cincinnati, Ohio, USA; wDivision of Biomedical Informatics, Children’s Hospital
Medical Center, Cincinnati, Ohio, USA; zDepartment of Surgery, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA
Cultured skin substitutes (CSS), prepared using keratinocytes, ﬁbroblasts, and biopolymers, can facilitate closure
of massive burn wounds by increasing the availability of autologous tissue for grafting. But because they contain
only two cell types, skin substitutes cannot replace all of the functions of native human skin. To better understand
the physiological and molecular differences between CSS and native skin, we undertook a comprehensive analysis
of gene expression in native skin, cultured keratinocytes, cultured ﬁbroblasts, and skin substitutes using
Affymetrix gene chip microarrays. Hierarchical tree clustering identiﬁed six major clusters of coordinately reg-
ulated genes, using a list of 1030 genes that were the most differentially expressed between groups. These clusters
correspond to biomarker pools representing expression signatures for native skin, ﬁbroblasts, keratinocytes, and
cultured skin. The expression analysis revealed that entire clusters of genes were either up- or downregulated upon
combination of ﬁbroblasts and keratinocytes in cultured skin grafts. Further, several categories of genes were
overexpressed in CSS compared with native skin, including genes associated with hyperproliferative skin or ac-
tivated keratinocytes. The observed pattern of expression indicates that CSS in vitro, which display a well-dif-
ferentiated epidermal layer, exhibit a hyperproliferative phenotype similar to wounded native skin.
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Tissue-engineered skin substitutes have become an impor-
tant adjunctive therapy for permanent wound closure in
patients with massive skin loss because of burn injury.
Composed of autologous keratinocytes alone (Carsin et al,
2000) or combined with autologous fibroblasts and biopol-
ymers (Boyce et al, 1995, 1999, 2002a), skin substitutes can
help restore epidermal barrier and facilitate permanent
wound closure in patients with insufficient donor sites for
autografting. But currently available skin substitutes, which
contain one or two cell types, can only replace a subset of the
structures and functions of native skin. Cultured skin substi-
tutes (CSS) containing fibroblasts and keratinocytes perform
similarly to autograft after healing, but engraftment can be
reduced because of inherent limitations in CSS composition
(Boyce et al, 1995, 2002a). Understanding the physiology of
CSS at the molecular level can help guide the engineering of
functional improvements for enhanced wound healing.
Expression of a limited number of genes involved in
wound healing has been examined in CSS in vitro. Multiple
growth factors are expressed by CSS, including basic fib-
roblast growth factor (bFGF), insulin-like growth factor 1,
platelet-derived growth factor A, and vascular endothelial
growth factor (VEGF) (Goretsky et al, 1996; Supp et al,
2000a, b; Swope et al, 2001). The cytokines interleukin (IL)-1a
and IL-6 were shown to be expressed in CSS; IL-1a ap-
peared to have been derived from the keratinocytes and
bFGF from the fibroblasts. IL-6 was not highly expressed in
either cell type alone, suggesting that it was induced upon
combination of fibroblasts and keratinocytes in CSS (Goret-
sky et al, 1996). Collagen IV, collagen VII, and laminin 5 are
expressed in CSS cultured in medium containing vitamin C,
demonstrating nutrient-dependent basement membrane
deposition (Boyce et al, 2002b). These studies provide in-
sight into the morphogenesis of CSS, but a deeper under-
standing can be gained by a comprehensive analysis of gene
expression using microarray technology. Expression analysis
may highlight deficiencies of CSS that can be addressed
using controlled culture conditions or genetic modifications.
Hypothetically, physiological deficiencies in CSS will be
reflected by differences in gene expression between native
skin and CSS. The goal of this study was to characterize
the gene expression profile of CSS, in comparison with
the constituent cell types and native human skin (NHS), us-
ing gene chip-based cDNA microarrays.
Results and Discussion
Microarray analysis and ﬁltering strategy Skin was ob-
tained from healthy adult females undergoing reduction
Abbreviations: CSS, cultured skin substitutes; ECM, extracellular
matrix; EDC, epidermal differentiation complex; IL, interleukin;
MMP, matrix metalloproteinases; NHS, native human skin
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mammoplasty or abdominoplasty, and cell cultures were
established that were used to prepare CSS (Fig S1). To
minimize artifacts because of individual genetic variation,
four biological replicates for each sample to be analyzed
(NHS, cultured fibroblasts, cultured keratinocytes, and CSS)
were isolated from isogenic sources (Table I). Complete
sample sets were isolated from two donors. For the re-
maining samples, the RNA isolated from NHS was not
sufficiently intact, based on Agilent Bioanalyzer data, for
microarray analysis, and was replaced with RNA from do-
nors with similar demographics.
The Affymetrix Human Genome HU133A gene chip,
which was used for microarray expression analysis, repre-
sents over 22,000 transcripts from mostly known genes.
Examination of the expression data revealed very consist-
ent expression patterns among the biological replicates in
each group, indicating relatively little variation because of
age, individual genetic differences, or skin biopsy site as
compared with relatively large differences between groups.
To analyze relative expression differences between sam-
ple groups, the expression levels for each gene were first
normalized to the median expression level across the three
in vitro cultured samples (CSS, fibroblasts, and keratin-
ocytes; see Materials and Methods). By doing so, gene ex-
pression differences between the in vitro cultured cell types
were emphasized and could be compared with expression
in NHS. In addition, gene expression differences between
the CSS and NHS because of the absence of cell types in
CSS (e.g., melanocytes, antigen-presenting cells, nerves,
fat, and endothelial cells) could be easily identified, as were
genes that are signatures of, or most relevant to, keratin-
ocytes and fibroblasts in the CSS.
A filtering strategy was employed to identify differentially
expressed genes in each group; technical details are de-
scribed in Materials and Methods. Briefly, eight lists were
generated, representing the most under- and overex-
pressed probe sets in each group relative to the other
groups. The top ranked probe sets were pooled, resulting in
a list of 1720 transcripts (Fig S2). For the purposes of this
report, we focused the cluster analysis on genes that were
overexpressed, rather than genes that were underex-
pressed in one group. This allowed us to filter out 690
probe sets that were underexpressed compared with me-
dian expression levels (see Fig S2). For example, that list
included genes such as plakophilin 1, desmoplakin, and
desmocollin 3, which were not expressed in fibroblasts, but
were expressed at similar levels in NHS, CSS, and keratin-
ocytes (data not shown). These three genes encode pro-
teins involved in formation of desmosomes, epithelial cell
junctions involved in cell adhesion and epidermal morpho-
genesis (Green et al, 1990; King et al, 1995; McGrath et al,
1997). Similarly, the larger list included several collagen
genes, including COL1A1, COL5A1, and COL6A2, which
are expressed at similar levels in NHS, CSS, and fibroblasts,
but are not expressed keratinocytes (data not shown);
genes with this expression pattern were filtered out in the
final cluster analysis. In addition, genes overexpressed in
the cultured monolayer cells, but underexpressed in CSS
and NHS, were in the list of 690 genes filtered out prior to
cluster analysis. Examples include genes involved in control
of the cell cycle and cytokinesis, such as cyclin A, protein
regulator of cytokinesis 1, and kinesin 4A (Page et al, 1992;
Jiang et al, 1998; Zhu and Jiang, 2005) (data not shown).
Signature genes The list of 1030 probe sets, representing
812 non-redundant genes that were relatively overex-
pressed, was subjected to hierarchical tree cluster analy-
sis resulting in identification of six major gene clusters (Fig 1
and Figs S2 and S3). These clusters correspond to groups
of coordinately regulated genes that represent expression
signatures for NHS, CSS, fibroblasts, or keratinocytes.
Cluster A includes transcripts that were expressed at high
levels in both NHS and in CSS, but at low levels in fibro-
blasts and keratinocytes. Cluster B contains genes that
were highly and specifically expressed in CSS. Cluster C
includes transcripts that were expressed at the highest lev-
els in NHS, although some of these genes were also mod-
erately expressed in CSS. Cluster C was sub-divided into
two smaller clusters, C1 and C2, based on middle-order
tree branches (Fig 1). Cluster D contains genes highly ex-
pressed in cultured fibroblasts, and Cluster E genes were
highly expressed in keratinocytes.
The cluster analysis revealed dramatic changes in gene
expression patterns upon combination of the two cell types,
fibroblasts and keratinocytes, in a three-dimensional matrix.
Note that genes in Clusters A and B were very low in fib-
roblast and keratinocyte monolayer cultures, but were up-
regulated upon combination of the cells in the CSS. Further,
genes expressed highly in fibroblast cultures (Cluster D) or
keratinocyte cultures (Cluster E) were downregulated in
CSS. These changes may reflect shifts in differentiation
state and proliferation levels of the cells in the cultured skin
compared with monolayer culture. This suggests paracrine
interactions between the cells in the context of the CSS,
and/or cellular responses to the changes in culture condi-
tions. The 15 most highly expressed genes in each cluster
Table I. RNA samples used for microarray expression analysis
Donor ID# 633 634 Ref 639 651 636
Donor age (y) 52 23 31 40 53 54
Tissue Abdomen Breast Breast Abdomen Breast Breast
Native human skin | | | |
Cultured fibroblasts | | | |
Cultured keratinocytes | | | |
Cultured skin substitutes | | | |
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are listed in Table II. The complete list of genes identified in
the cluster analysis is presented in Fig S3.
To characterize the major biological functions or proc-
esses associated with the genes in each cluster, we used
the approach of ontological association analysis (see Table
S1). For each expression pattern cluster, a significance val-
ue was calculated based on the probability of there being a
greater number of genes associated with a particular Gene
Ontology (http://www.geneontology.org/) grouping in the
cluster than would be expected based on random chance.
Thus, a low p-value indicates a highly significant association
of a particular function and that cluster. For example, in
Cluster B, 28 probe sets (representing 18 non-redundant
genes) were classified as adhesion related, with a p-value of
1.03  1017. This indicates that genes within this category
are highly overrepresented in Cluster B compared with what
would be expected by chance. Other functional categories
that were identified in these analyses include apoptosis, cell
growth and maintenance, collagen, extracellular matrix
(ECM), intermediate filaments, proliferation, proteases, sig-
nal transduction, and transport (Table S1). The complete
data sets can be accessed online at http://genet.cchmc.org
(see Materials and Methods).
Cluster A This cluster contains genes that were highly ex-
pressed in CSS and also NHS, but were expressed at very
low levels in fibroblasts and keratinocytes. Genes encoding
several ECM proteins, which have a critical role in the
structural integrity and mechanical strength of skin, were
expressed similarly in CSS and NHS. Fibromodulin, decorin,
and lumican, all members of the leucine-rich repeat pro-
teoglycan family, were expressed at similar levels in CSS
and NHS (Fig S3). These proteins function in collagen
network assembly by binding to collagen fibrils (Svensson
et al, 2000). Also found in Cluster A were matrix metal-
loproteinases MMP2 and MMP11, proteins involved in de-
grading ECM, which were both expressed in CSS and NHS,
but at higher levels in CSS.
Cluster A was also highly enriched in genes associated
with the biological process of signal transduction
(p¼2.25  1010; Table S1). Examples of genes in this cat-
egory include cellular retinoic acid binding protein 2, retinoic
acid receptor-related orphan receptor A, signal transducer
and activator of transcription 3, src homology 2 domain
containing transforming protein C3 (SHC3), IL-8 receptor b
(IL8RB/CXCR2), and multiple chemokines (CCL2, CCL8,
CCL19, and CXCL12).
Among the genes most differentially upregulated in Clus-
ter A were genes involved in epidermal differentiation. These
include several genes (S100A7, SPRR2B, filaggrin, in-
volucrin, and NICE-1) that map to the epidermal differen-
tiation complex (EDC) (Mischke et al, 1996; Marenholz et al,
2001), a 2-megabase region of chromosome 1q21 contain-
ing multiple families of genes that are involved in formation
of the cornified envelope of the epidermis or in regulation of
keratinocyte terminal differentiation. The EDC contains at
least 11 S100 proteins expressed in keratinocytes or in hu-
man epidermis, which function as mediators of calcium-
associated signal transduction (Eckert et al, 2004). The
S100A7 gene, also called psoriasin, was very highly ex-
pressed in CSS and, to a lesser degree, in NHS. This par-
ticular S100 family member is upregulated in psoriatic
epidermis and has antimicrobial activity (Madsen et al,
1991; Glaser et al, 2005). Involucrin and small proline-rich
Figure 1
Hierarchical cluster analysis of normalized gene expression in native human skin (NHS), cultured skin substitutes (CSS), fibroblasts, and
keratinocytes. Samples from the different donors are indicated on the column labels, and a total of 1030 genes are displayed on the y-axis (see Fig
S3 for the list of genes, GenBank Accession Numbers, and quantitative expression data). Clusters A–E are indicated on the right of the figure, and
the hierarchal tree is shown at the left. The white bracket indicates genes in Cluster C1 that are increased in CSS samples. Red color indicates high
level expression, green color indicates low expression, and black indicates median expression.
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proteins (SPRR), including SPRR2B, are precursors of the
cornified envelope and are critical for skin barrier function.
Both of these genes were expressed at relatively higher
levels in CSS compared with NHS, and were higher in both
tissues compared with cultured fibroblasts or keratinocytes
(Table II and Fig S3). Also linked to the EDC are multiple
NICE proteins; NICE-1 was upregulated in CSS compared
with fibroblasts and keratinocytes, and was also highly ex-
pressed in NHS. The function of NICE-1 is unclear, but it is
thought to have a role in epidermal differentiation because it
is upregulated in differentiated keratinocytes (Marenholz
et al, 2001).
There were additional differentiation-associated genes in
Cluster A that are unlinked to the EDC, including the keratin
intermediate filament genes keratins 1, 10, and 23, the
cornified envelope glycoprotein corneodesmosin (Simon
et al, 1997), and the psoriasis susceptibility locus
PSORSC1C (Holm et al, 2003). Further, the ARS/SLURP-1
gene (secreted Ly-6/uPAR related protein) was highly ex-
pressed in both CSS and NHS. SLURP-1 is believed to
function in skin homeostasis, and is mutated in the auto-
somal recessive skin disorder Mal de Meleda, which is char-
acterized by diffuse palmoplantar keratoderma (Chimienti
et al, 2003; Eckl et al, 2003).
Cluster B This cluster contains genes that were highly ex-
pressed in CSS and were expressed at low levels or absent
from NHS, fibroblasts, and keratinocytes. Thus, Cluster B
represents genes that were upregulated upon combination
of fibroblasts and keratinocytes for preparation of CSS, and
were relatively specific to CSS compared with NHS. Exam-
ination of the functions of genes present in this cluster
Figure 3
Relative expression of genes involved in ep-
idermal differentiation and hyperproliferation.
Shown are mean normalized expression levels;
error bars represent  standard deviations. All
genes shown were expressed at significantly
higher levels (t test) in cultured skin substitutes
(CSS) compared with native human skin (NHS)
(po0.05).
Figure 2
Localization of MMP10 and TIMP3 in native
human skin (NHS) and cultured skin substi-
tutes (CSS). (A, B) Immunostaining of NHS and
CSS, respectively, with anti-MMP10 antibody.
(C, D) Anti-TIMP3 staining in NHS and CSS, re-
spectively. Epidermis is at the top of each panel;
scale bar¼0.2 mm.
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reveals important information about the physiology of CSS,
and characteristics that distinguish CSS from NHS.
Genes involved in cell proliferation were highly enriched
in Cluster B (p¼4.01  109; Table S1), and keratinocyte
mitogens were highly expressed in CSS. For example, IL-6
was among the most highly expressed transcripts in Cluster
B (Table II). IL-6 is a proinflammatory cytokine that has been
shown to stimulate the proliferation and migration of kera-
tinocytes, and it is expressed at high levels in psoriasis
(Grossman et al, 1989; Olaniran et al, 1995). Also expressed
at high levels in CSS was the endothelin-1 receptor EDNRA
(Fig S3), which participates in autocrine signaling of
keratinocyte proliferation (Bagnato et al, 1995; Venuti et al,
1998).
Proteases involved in digestion of the ECM were among
the most highly expressed genes in Cluster B. MMP9 and
MMP10 were expressed at high levels in CSS (Table II); a
third related gene in Cluster B, MMP3, was also elevated in
CSS compared with NHS (Fig S3). The MMPs make up a
large family of enzymes that, as a whole, are capable of
Figure 4
Immunohistochemical localization of keratins
and differentiation markers in native human
skin (NHS) and cultured skin substitutes
(CSS). Shown are sections of NHS (left column;
A, C, E, G, I) and CSS (right column; B, D, F, H,
J), stained with antibodies against human keratin
10 (A, B), keratin 5/8 (C, D), keratin 16 (E, F),
lipocalin 2 (G, H), or SERPINB3/B4 (I, J). Arrow in
panel G indicates positive lipocalin 2 staining in
hair follicle. Scale bars¼ 0.1 mm.
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degrading essentially all ECM components. MMP3 and
MMP10 (also called stromelysin 1 and stromelysin 2, re-
spectively) degrade proteoglycans and are expressed dur-
ing wound repair (Madlener et al, 1998). MMP3 expression
has been reported in fibroblasts (Sirum and Brinckerhoff,
1989) as well as keratinocytes (Madlener et al, 1998),
whereas MMP10 is limited to keratinocytes and is increased
in wounds at the tip of the migrating epithelium (Madlener
et al, 1998; Krampert et al, 2004). MMP9, also called gel-
atinase B, degrades denatured collagen and is expressed in
wounds in both the granulation tissue and in the hyperpro-
liferative migrating epithelium (Madlener et al, 1998). Con-
sistent with previous reports, MMP10 protein in CSS was
localized to the epidermal layer, and was also observed in
the epidermis of NHS (Fig 2). Interestingly, TIMP-3, a phys-
iological inhibitor of MMP, was found by immunohistochem-
istry to be expressed in NHS and CSS (Fig 2). The
expression of MMP and TIMP-3 in CSS suggests that the
cells are actively remodeling the ECM to facilitate cell
proliferation, migration, and differentiation into a stratified
epithelium.
Consistent with the increased MMP expression observed
in CSS, examination of other genes in Cluster B reveals a
profile of gene expression suggestive of epidermal differ-
entiation and hyperproliferation, resembling a wound-heal-
ing phenotype. Several genes that encode proteins of the
cornified envelope, inflammatory mediators, angiogenic
factors, and markers of abnormal keratinocyte differentia-
tion were expressed at significantly higher levels in CSS
compared with NHS (Fig 3). For example, one of the most
highly expressed genes in Cluster B was protease inhibitor
3 (PI3), also called skin-derived antileukoproteinase
(SKALP) or elafin, which is expressed at very low levels in
normal skin but is upregulated in psoriasis (Nakane et al,
2002). PI3 is a constituent of the keratinocyte cornified en-
velope, where it co-localizes with involucrin. Similarly, the
gene encoding keratin 16 (KRT16), an intermediate filament
that contributes to the structural scaffold of epidermal ker-
atinocytes, was expressed at very low levels in native skin
but was significantly higher in CSS (Fig 3). This keratin is
upregulated during a process termed keratinocyte activa-
tion, which occurs during wound healing, and is markedly
overexpressed in epithelia that display abnormal differenti-
ation, such as psoriatic epidermis (Coulombe et al, 1995;
Padilla et al, 1996; Coulombe, 1997). At the protein level,
immunohistochemistry showed that in contrast to keratins 5
and 10, which are not known to be increased in activated
keratinocytes, keratin 16 was dramatically increased in CSS
compared with NHS (Fig 4). Small proline-rich protein
SPRR1A, which encodes a major precursor of the corni-
fied envelope, is linked to involucrin in the EDC on chro-
mosome 1q21 (Marenholz et al, 2001). Like PI3 and KRT16,
SPRR1A is highly expressed in differentiating epithelia and
in psoriasis (Hohl et al, 1995; Fujimoto et al, 1997), and was
also expressed at significantly higher levels in CSS com-
pared with NHS (Fig 3). Other members of the EDC, such as
S100A8, S100A9, and S100A12, were also present in Clus-
ter B and expressed at very high levels in CSS (Table II; Fig
3). These calcium-binding proteins are expressed minimally
in normal skin but are upregulated in psoriasis (Eckert et al,
2004).
Multiple chemokines and cytokines with putative roles in
the pathogenesis of psoriasis were expressed at signifi-
cantly higher levels in CSS compared with NHS (Fig 3). For
example, CCL20 expression was 13.5-fold higher in CSS
than in NHS. This member of the C–C chemokine family,
also called macrophage inflammatory protein-3a (MIP-3a),
is expressed in skin after barrier disruption (Schmuth et al,
2002), in psoriatic epidermis (Homey et al, 2000), and in
differentiating cultured keratinocytes (Pernet et al, 2003).
CCL20 has been shown to direct the migration of dendritic
cells and lymphocytes to sites of antigen invasion, and was
proposed to play a role in immunosurveillance in inflamma-
tory skin conditions such as psoriasis (Homey et al, 2000;
Schmuth et al, 2002). The C–X–C chemokine CXCL1, also
referred to as growth-related oncogene a, and IL-8 are both
overexpressed in psoriatic epidermis where they are pro-
posed to influence neutrophil migration and activation (Gill-
itzer et al, 1996). CXCL1 and IL-8 were elevated 21.6- and
7.7-fold, respectively, in CSS compared with NHS (Fig 3).
Cluster analysis indicates that angiogenic genes, which
have been implicated in cutaneous inflammation and pso-
riasis, were also increased in CSS compared with NHS.
Endothelial cell growth factor 1 (ECGF1, or platelet-derived
ECGF) is overexpressed in psoriatic epidermis, which may
contribute to the microvascular changes observed in lesio-
nal skin (Creamer et al, 1997). Placental growth factor, a
member of the VEGF family, has also been associated with
pathologic angiogenesis and has a proposed role in the
control of cutaneous inflammation (Oura et al, 2003). These
angiogenic growth factors were both present in Cluster B,
and were significantly overexpressed in CSS compared with
NHS (Fig 3).
Increased or abnormal epidermal differentiation is a hall-
mark of psoriasis, and several genes that are associated
with keratinocyte differentiation and are increased in pso-
riasis were present in Cluster B. For example, lipocalin 2
(LCN2), also called neutrophil gelatinase-associated lip-
ocalin (NGAL), a marker for dysregulated differentiation in
keratinocytes (Mallbris et al, 2002), was among the most
highly expressed genes in Cluster B. LCN2 expression in
normal skin is restricted to hair follicles, but strong epider-
mal expression is observed in lesional skin from psoriasis
patients (Mallbris et al, 2002). In CSS, high levels of LCN2
protein were found in the epidermis (Fig 4), but in the cor-
responding NHS, expression was found only in hair follicles,
consistent with previous reports (Mallbris et al, 2002). Serine
protease inhibitors SERPINB3 and SERPINB4, also referred
to as squamous cell carcinoma antigens SCCA1 and
SCCA2, were expressed at approximately 9- and 25-fold
higher levels, respectively, in CSS compared with NHS.
These proteins were identified in sera of psoriasis patients
and localized to the epidermis of lesional skin (Takeda et al,
2002a). Immunohistochemistry with an antibody that rec-
ognizes both SERPINB3 and SERPINB4 showed expres-
sion in both CSS and NHS, but at relatively higher levels in
CSS (Fig 4). Epidermal fatty acid binding protein (FABP5),
which is involved in lipid transport and metabolism in the
epidermis is also overexpressed in differentiated keratin-
ocytes in normal and psoriatic epidermis (Siegenthaler et al,
1994), was expressed at significantly higher levels in CSS
than NHS (Fig 3). Interestingly, FABP5 has been shown to
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co-localize with S100A7 (psoriasin), a Cluster A gene that is
also overexpressed in psoriasis, and this complex may tar-
get FABP5 to specific subcellular locations (Ruse et al,
2003).
The S100A7 gene, which was identified in Cluster A and
thus was elevated in both NHS and CSS, has been shown
to have antimicrobial activity (Glaser et al, 2005). In Cluster
B, the antimicrobial peptide gene DEFB4 (formerly called
human b-defensin-2) was among the most highly expressed
genes. Expression of DEFB4 is regulated by cytokines, in-
cluding IL-1 and IL-6, and epidermal differentiation (Erdag
and Morgan, 2002; Liu et al, 2002). Originally identified from
psoriatic skin, DEFB4 peptide plays an important role in the
innate cutaneous immune system (Harder et al, 1997; Sch-
roder and Harder, 1999). A previous study demonstrated
expression of DEFB4 protein in CSS (Supp et al, 2004). In
this study, microarray analysis showed that expression of
DEFB4 RNA in CSS was approximately 25-fold higher than
in NHS, and 29-fold higher than in fibroblasts or keratin-
ocytes (Fig 3 and Table II).
The dramatic increases in expression of Cluster B genes
in CSS compared with monolayer cultures suggests that the
upregulation may result from combination of fibroblasts and
keratinocytes. Additional influences on the expression pro-
files of cells in the context of CSS may include the com-
position of the nutrient medium, which has a higher calcium
concentration (1.8 mM) compared with keratinocyte growth
medium (Boyce, 1999; Swope et al, 2001), and the culture
format, composed of a stratified three-dimensional air-ex-
posed tissue. These culture conditions have been optimized
to enhance epidermal differentiation and stratification (Boy-
ce, 1999; Swope et al, 2001; Boyce et al, 2002b). Because
differentiated epidermal keratinocyte cultures have been
shown to upregulate genes involved in terminal differenti-
ation, barrier formation, and host protection (Jansen et al,
2001), the state of keratinocyte differentiation in the CSS
may account for some of the observed gene expression
changes. Further, the relatively high cell density in the CSS
may facilitate cell–cell interactions within and between cell
types that could modulate gene expression.
Cluster C1 Cluster C contains genes that are the most
highly and specifically expressed in NHS, although some of
these genes are also expressed in CSS, CF, or CK. To fa-
cilitate the analysis, Cluster C was sub-divided based on
middle-order hierarchical tree branches (Fig 1). An overview
of the genes represented in Cluster C1 reveals a significant
number of genes involved in pathogenesis and immunity
(p¼ 8.01  1021; Table S1), including eight of the 15 most
highly expressed genes in this cluster: HLA class II genes
HLA-DRB3, HLA-DRA, HLA-DR-g (CD74), HLA-DPA1, and
HLA-DQA1; FCER1A, the a subunit of the IgE receptor; and
the antimicrobial agent lysozyme (LYZ) (Table II). Two addi-
tional genes in the top 15, tyrosinase-related protein 1 and
dopachrome tautomerase, are expressed in melanocytes
and are required for biosynthesis of the pigment melanin.
These 10 genes are specific for NHS because they are nor-
mally expressed in cells that are not present in CSS and
they would not be expected to be expressed in fibroblasts
or keratinocytes. The apparent low level of expression of
these genes in the cultured samples probably reflects a very
low level persistence of contaminating cell types in the fib-
roblast and/or keratinocyte primary cultures. This has been
documented previously for melanocytes, which can persist
as ‘‘passengers’’ in keratinocyte cultures and result in foci of
pigmentation in cultured skin grafts prepared with these
cells (Swope et al, 1997).
Among genes in Cluster C1 that are not involved in either
immune response or pigmentation were a number of genes
associated with epidermal differentiation, including four of
the top 15 most highly expressed genes (Table II). The
genes encoding loricrin (LOR), keratin 2A (KRT2A), small
proline-rich-like 1B (SPRL1B), and calmodulin-like skin pro-
tein (CALML5) are expressed at relatively high levels in NHS
and also in CSS (Table II). LOR and SPRL1B both map to
the EDC on chromosome 1q21, and are major components
of the epidermal cornified envelope (Marenholz et al, 2001).
The product of the CALML5 is localized to the stratum
corneum (Mehul et al, 2000) and KRT2 is only found in
suprabasal epidermal cell layers (Collin et al, 1992). These
genes fall at the top of Cluster C1; note that many of the
genes at the top of this hierarchical cluster are moderately
expressed in CSS as well as highly expressed in NHS (Fig 1
and Fig S3). Further, CSS from cell strains 633 and 634 have
slightly different patterns of expression for multiple genes
involved in epidermal differentiation, compared with 639
and 651 (Fig 1, white bracket; see also Fig S3). The results
suggest that, although there were no significant histological
differences that distinguished these grafts (Fig S1), and their
expression profiles were highly similar overall, for some
groups of genes there were subtle expression differences.
Cluster C2 This cluster contains genes that were highly
expressed in NHS, including a number of genes expressed
at intermediate levels in keratinocytes, CSS, or fibroblasts.
In contrast to Cluster C1, fewer of the genes in Cluster C2
were involved antigen presentation or the immune system.
Among the most highly expressed genes in Cluster C2
were the ECM genes SPARCL1, tetranectin (TNA), and de-
rmatopontin (DPT) (Table II). SPARCL1, a secreted glyco-
protein widely expressed in multiple tissues, is considered a
matricellular protein because it modulates cell–ECM inter-
actions but does not directly contribute to ECM architecture
(Hambrock et al, 2003; Brekken et al, 2004). Although the
exact function of SPARCL1 in skin is unclear, it has been
shown to inhibit cell adhesion in vitro (Hambrock et al,
2003). TNA is a C-type lectin protein that binds plasminogen
in the ECM. It is widely expressed, although its expression
may be elevated in some tumors, and it has been suggested
to function in tissue remodeling (Ibaraki et al, 1995; Iba et al,
2001). Like SPARCL1 and TNA, DPT is widely distributed
throughout the body. DPT is associated with decorin in the
ECM, where it functions in cell adhesion, collagen fibril
formation, and regulation of skin elasticity (Takeda et al,
2002b).
Other noteworthy genes present in Cluster C2 include
the secreted factors CXCL14 and Wnt4 (Table II). The
chemokine CXCL14 is expressed in many normal human
tissues, but expression is absent in many tumor cell lines
and cancers. Originally cloned from oral epithelial cells,
CXCL14 was shown to inhibit angiogenesis, suggesting
its loss may be associated with tumor vascularization
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(Shellenberger et al, 2004). Because many pro-angiogenic
genes are upregulated in CSS, it is not surprising that
CXCL14 is expressed at relatively lower levels in CSS com-
pared with NHS. Wnt-4 is a member of the highly conserved
Wnt family of secreted glycoproteins, which have been
shown to regulate cell fate and differentiation. Wnt-4 signal-
ing is involved in the developmental cascade leading to sex
determination in humans (Jordan et al, 2001), is required for
kidney development in mice (Stark et al, 1994), and is im-
portant for epithelial–mesenchymal interactions in the skin
(Saitoh et al, 1998; Bhatia and Spiegelman, 2005). Interest-
ingly, the transcription factor Tcf4, which participates in the
Wnt/b-catenin/Tcf signaling pathway, is also present in
Cluster C2 and was expressed at relatively higher levels in
NHS compared with CSS (Fig S2). TCF genes act down-
stream of Wnt to regulate transcription of Wnt target genes.
Recent studies showed that mouse skin tumors express
high levels of Wnt4, and inhibition of Tcf4 signaling inhibited
growth of skin cancer cells, suggesting that these genes
may play a role in skin carcinogenesis (Bhatia and Spiegel-
man, 2005).
Cluster D This cluster contains genes that were very highly
expressed in fibroblast cultures. These genes were ex-
pressed at relatively low levels in most other samples, al-
though slightly elevated relative expression of many Cluster
D genes was observed in CSS from strains 633 and 634
compared with strains 639 and 651 (Fig 1 and Fig S3). This
may be because of individual genetic differences or to sub-
tle differences in the rates of differentiation or development
of the CSS, rather than age- or tissue-specific differences,
because these variables did not correlate with differences in
gene expression levels (Table I). Nearly half of the most
highly expressed genes in Cluster D are involved in signal
transduction, including guanine nucleotide binding protein
gamma 11 (GNG11), epidermal growth factor receptor
pathway substrate 8 (EPS8), prostaglandin E receptor 2
(PTGER2), cytokine receptor-like factor 1 (CRLF1), and pro-
tein kinase C, mu (PRKCM) (Table II). The gene that was
most highly expressed in fibroblasts, relative to keratin-
ocytes and CSS, was glioma pathogenesis-related protein
(GLIPR1) (Table II). The GLIPR1 gene is highly expressed in
human brain tumors (glioblastomas and astrocytomas), but
expression was not previously identified in adult tissues or
primary cell cultures, suggesting a possible role in tumor
cell growth (Murphy et al, 1995). Human GLIPR1 has struc-
tural similarities with plant pathogenesis-related proteins
that are induced in response to infection (Murphy et al,
1995), and the mouse homolog has been proposed to pro-
mote cell apoptosis (Ren et al, 2002). Another gene in Clus-
ter D with putative pro-apoptotic activity is the cannabinoid
receptor 1 gene (CNR1), which was highly expressed in
fibroblasts compared with lower expression in CSS, NHS,
and keratinocytes (Table II). CNR1 is highly expressed in the
brain, where it is responsible for the psychoactivity of can-
nabinoids (Casanova et al, 2003). It was found in the skin,
and activation of CNR1 was shown to induce skin tumor
regression by inhibiting tumor angiogenesis and promoting
tumor cell apoptosis (Casanova et al, 2003). Interestingly,
BAG-2, which encodes a chaperone protein associated
with BCL2, was also highly expressed in fibroblasts. BAG-
family genes are overexpressed in many cancers, and can
increase cell survival and decrease apoptosis. The high
level of expression of both anti- and pro-apoptotic genes,
as well as several genes involved in cell proliferation and
signal transduction, suggests a balance of positive and
negative regulators to maintain the proliferative potential of
fibroblasts in monolayer culture, which is shifted upon com-
bination with keratinocytes in the three-dimensional culture
model.
Cluster E This cluster contains genes that were the most
highly expressed in sub-confluent keratinocyte monolayer
cultures, relative to fibroblasts and CSS. Functional groups
highly enriched in Cluster E include cell communication
(p¼2.51  1027), signal transduction (p¼1.56  1028),
and structural proteins (p¼ 4.98  1025), among others
(Table S1). In Cluster E, the most highly expressed gene
relative to fibroblasts and CSS was parathyroid hormone-
like protein (PTHLH), which regulates epithelial–me-
senchymal interactions during development of the teeth
and mammary glands and differentiation of keratinocytes in
adult skin (Foley et al, 1998). Two growth factors that
regulate keratinocyte proliferation and differentiation, ne-
uregulin 1 (NRG1), and amphiregulin (AREG), were also
highly expressed in keratinocytes (Table II). Other investi-
gators observed expression of these genes in conditioned
medium from primary keratinocytes and have proposed
roles for these factors in cell migration and growth regula-
tion (Schelfhout et al, 2002). Expression levels of PTHLH,
NRG1, and AREG are decreased in CSS compared with
keratinocytes in monolayer culture, suggesting that their
expression may be downregulated by factors produced by
fibroblasts or by the three-dimensional culture format.
Conclusions
The microarray expression analysis described here revealed
that many CSS signature genes are also expressed at sim-
ilar levels in NHS (Cluster A), but there are also clusters of
genes, specifically Clusters B, C1, and C2, which are dif-
ferentially expressed. In contrast, other groups of investi-
gators have observed relatively similar gene expression
profiles in native skin compared with reconstituted epider-
mis (Bernard et al, 2002; Gazel et al, 2003). The cultured
skin model utilized in those studies, SkinEthic, contains only
keratinocytes, suggesting that some of the differences
observed between CSS and NHS in this study may be
because of the presence of fibroblasts.
Over 200 genes were identified that were overexpressed
in NHS compared with CSS. We utilized a normalization
scheme that de-emphasized the majority of genes ex-
pressed in structures absent from CSS, such as blood ves-
sels and nerves. But, because the CSS are prepared with
low-passage primary cell cultures, some residual non-fib-
roblast or non-keratinocyte cells may have been present.
Many of the genes expressed specifically in NHS function in
immune regulation, but we hypothesized that the cluster
analysis would identify molecular deficiencies of the CSS
compared with native skin. Thus, genetic modification may
be useful for targeted overexpression of transcripts that are
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missing from CSS, and may enhance the morphogenesis of
skin substitutes in culture.
A major finding from this study was that the gene ex-
pression profile of CSS was very different than the sum of
genes expressed in fibroblasts and keratinocytes. There
were hundreds of genes identified that were either down- or
upregulated upon combination of the two cell types in the
context of cultured skin. This suggests an influence of me-
senchymal–epithelial interactions between the fibroblasts in
the dermal matrix and the epidermal keratinocytes on gene
expression, although culture conditions may also be impor-
tant. Skin replacements composed only of keratinocytes will
form a stratified epidermal layer in culture, but their clinical
performance is variable (Carsin et al, 2000). The importance
of a dermal component in skin substitutes, not only for ease
of transplantation but also for optimal in vitro epidermal
development, is now well recognized. The role played by
fibroblasts has been supported by other investigators, who
showed that diffusible factors released by fibroblasts reg-
ulate epidermal morphogenesis (El Ghalbzouri and Ponec,
2004).
The expression profile of CSS showed overexpression,
relative to cultured monolayer cells and normal human skin,
of clusters of genes that are known to be overexpressed in
hyperproliferative skin disorders and during wound healing.
These genes include cytokines, growth factors and recep-
tors, antimicrobial proteins, and differentiation markers. The
analysis suggests that the keratinocytes in CSS are present
in an activated state, similar to wounded human skin. Com-
bined with the expression patterns of MMP observed in
CSS, these findings are consistent with remodeling of the
dermal matrix and differentiation of a stratified epidermal
layer, processes that are observed during wound healing.
Although many of the genes that were upregulated in CSS
are also increased in psoriasis, the CSS do not display a
psoriatic phenotype, either in vitro (Fig S1) or after grafting
to patients (Boyce et al, 2002a). This indicates a balance of
proliferation and differentiation factors in the CSS that may
shift during in vitro culture and after grafting in vivo. Future
studies will be required to examine the kinetics of the gene
expression changes, and to determine how expression is
regulated after grafting to wounds.
Materials and Methods
Preparation of CSS Human skin samples were obtained with In-
stitutional Review Board approval and in accordance with the
Declaration of Helsinki Principles, from breast and abdominal tis-
sue of healthy adult females. Informed consent was not required
because the skin was obtained from discarded surgical tissues.
Biopsies of the skin were stored in RNAlater (QIAGEN Inc., Valen-
cia, California) for subsequent RNA purification, and additional bi-
opsies were frozen and embedded for histological sections. One of
the skin samples is a reference sample (Table I, ‘‘Ref’’) used as a
calibration standard for all microarray analyses done in our labo-
ratory. Fibroblasts and keratinocytes were isolated from fresh skin,
cultured separately in growth medium specific for each cell type
(Boyce and Ham, 1985; Boyce, 1999), and expanded for a max-
imum of two passages prior to harvest for preparation of CSS. CSS
were prepared with cells from four independent donors (N¼ 8 total;
two per donor) as described in detail elsewhere (Boyce, 1999;
Boyce et al, 2002a). Briefly, fibroblasts were grown to confluence
(95%–100%) and were harvested and inoculated onto collagen–
glycosaminoglycan polymer substrates (Boyce et al, 1988) at a
density of 5  105 per cm2. Keratinocytes were harvested at sub-
confluence (85%–90%) and inoculated onto the dermal substrates
1 d following fibroblast addition, at a density of 1  106 per cm2.
Samples of both cell types to be used for RNA isolation were col-
lected when cells were harvested for CSS inoculation. CSS were
cultured at the air–liquid interface for 2 wk in vitro, using specific
CSS maturation medium described in detail elsewhere (Boyce
et al, 2002b). A 2-wk in vitro incubation has been shown to be
optimal for development of mature epidermal barrier and basement
membrane deposition (Boyce et al, 1996, 2002b), and is compa-
rable with the culture period utilized for preparation of CSS for
grafting to burn patients (Boyce et al, 1999, 2002a). Epidermal
barrier development in vitro was evaluated by measuring surface
electrical capacitance (SEC) using a dermal phase meter (NOVA
DPM 9003; NOVA Technology Corp., Gloucester, Massachusetts);
a decrease in SEC during in vitro incubation indicates reduced
surface hydration and increased epidermal barrier (Boyce et al,
1996, 2002b). Biopsies of CSS were collected at the end of the
culture period for histological examination to ensure optimal mor-
phology (Fig S1), and for RNA isolation and immunohistochemistry.
Microarray analysis Quantitative analysis of RNA expression was
performed using Affymetrix gene chip cDNA microarrays (Affyme-
trix, Santa Clara, California). Samples of fibroblasts and keratin-
ocytes, as well as biopsies of the NHS and CSS in vitro (N¼ 4
independent donors each), were used for preparation of total RNA
samples using the RNeasy Mini Kit (QIAGEN Inc.), followed by
phenol and chloroform extraction and ethanol precipitation. RNA
quality was measured using the Agilent Bioanalyzation system
(Agilent Technologies Inc., Palo Alto, California), to ensure the in-
tegrity of the RNA. cDNA synthesis and hybridization to the
Affymetrix Human Genome HU133A gene chip was performed by
the Affymetrix Gene Chip Core Facility at Cincinnati Children’s
Hospital Medical Center (Cincinnati, Ohio) using standard proto-
cols. To check the reproducibility of the hybridization data, two of
the RNA samples were analyzed in duplicate; results of these du-
plicate chips were essentially identical (data not shown), confirm-
ing the fidelity of the analysis.
The hybridized arrays were scanned using Microarray Suite
(MAS) Software (Affymetrix), and were analyzed with GeneSpring
7.1 (Silicon Genetics, Redwood City, California) using Affymetrix
MAS 5.0 cel files subjected to the RMA (Irizarry et al, 2003) cel file
pre-processor built in to GeneSpring 7.1. The raw data from this
study have been deposited into the NCBI GEO database (Acces-
sion number GSE3204). To analyze the data, the values for RNA
expression were first converted to relative levels by referencing the
RMA-generated per-chip and per-array series expression value
data to the median expression values of the in vitro samples (fib-
roblasts, keratinocytes, and CSS). To identify differentially ex-
pressed genes from each group, an initial four-way analysis of
variance (ANOVA) using Student’s t test with a false discovery rate
cutoff of 0.05 using the Benjamini Hochberg test was used. This
identified a total of 12,483 probe sets, which were then consist-
ently filtered based on rank most under- and overexpressed com-
pared with the median for each of the four sample groups. This led
to a list of 1720 probe sets, which were finally filtered for those
probe sets that were overexpressed in any of the four sample types
(Fig S2). This final list was comprised of 1030 probe sets, with the
remaining 690 probe sets representing genes that are much less
expressed in one or two samples compared with the median ex-
pression in the cultured samples. We concentrated our character-
izations on the 1030 probe set list to allow us to focus on genes
that are highly expressed in one or two sample groups, rather than
genes that are in common between groups. This list of 1030 probe
sets was subjected to hierarchical clustering using standard cor-
relation metric to obtain clusters of coordinately regulated genes
representing the transcriptional signatures of human skin relative
to keratinocytes, fibroblasts, and CSS. Top-level hierarchical tree
branches were used to form six major clusters (Fig 1).
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Ontological data mining was performed using tools in Gene-
Spring 7.1. The functional data obtained in this analysis, including
the functional categories and lists of genes referred to in Table S1,
are available online at http://genet.cchmc.org. To access the data
from this website, login as a guest, choose the option ‘‘HG-U133,’’
open the ‘‘Experiments’’ folder, and select the file named ‘‘Smiley-
EtAl_2005.’’
Histology and immunohistochemistry For immunohistochemis-
try, biopsies of NHS and CSS in vitro were imbedded frozen
using M1 embedding matrix (Lipshaw, Pittsburgh, Pennsylvania).
Immunostaining was performed using the following antibodies:
rabbit anti-human MMP10, 1:200 dilution (Abcam Inc., Cambridge,
Massachusetts); rabbit anti-TIMP3, 1:40 dilution (Abcam Inc.);
mouse anti-human cytokeratin 10, 2 mg per mL (US Biological,
Swampscott, Massachusetts); mouse anti-human cytokeratin 5/8,
2 mg per mL (US Biological); mouse anti-human cytokeratin 16, 1
mg per mL (US Biological); mouse anti-human NGAL (lipocalin 2),
25 mg per mL (Accurate Chemical & Scientific Corp., Westbury,
New York); rabbit anti-human SCCA1/2, 1 mg per mL (Santa Cruz
Biotechnology Inc., Santa Cruz, California). Sections were incu-
bated with primary antibodies for 1 h at room temperature in a
humidified chamber. Antibody detection utilized the Vectastain
Elite ABC Universal Kit with DAB substrate (Vector Laboratories,
Burlingame, California), and sections were counterstained using
Hematoxylin QS (Vector Laboratories). For negative controls, serial
sections were incubated in parallel with either non-immune Rabbit
IgG or non-immune mouse IgG (R&D Systems, Minneapolis, Min-
nesota), or without antibody (data not shown). Sections were ex-
amined using a Microphot-FXA microscope (Nikon, Melville, New
York) and were photographed using a Spot-Jr. Digital Camera (Di-
agnostic Instruments Inc., Sterling Heights, Missouri).
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